Pure Global AI
NCT06360783Recruitment Completed

COVID-19 Quick Start - Test and Treat in Africa

Evaluation of a COVID-19 Quick Start Test and Treat Model in Africa
Duke UniversityClinicalTrials.gov
Verified
Study focus
Disease/Condition
COVID-19
Study type
Observational
Sponsor & location
Primary sponsor
Duke University
Location
Durham, United States of America
Timeline & enrollment
Phase
N/A
Start date
Feb 01, 2023
End date
Jun 01, 2024
Enrollment
1000 participants
Primary outcome

Stakeholder Perspectives

Summary

Duke University and the Clinton Health Access Initiative (CHAI), in partnership with the
 Ministries of Health (MoH) of Ghana, Malawi, Rwanda, Zambia, and Zimbabwe, aim to assess the
 implementation and impact of COVID-19 test -and -treat (T&T) demonstration programs

ICD-10 classifications
COVID-19, virus identifiedCOVID-19, virus not identifiedCoronavirus infection, unspecified siteViral infection, unspecifiedRift Valley fever
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06360783
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06360783 through Pure Global AI's free database. This phase not specified trial is sponsored by Duke University and is currently Recruitment Completed. The study focuses on COVID-19. Target enrollment is 1000 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.